Published in:
01-06-2012 | Original Article
Does domperidone, a D2-antagonist alter gastric emptying rates and appetite sensations in healthy adults with high-fat meal? A block-randomised, single-blind placebo-controlled study
Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2012
Login to get accessAbstract
Background
Accelerated gastric emptying (GE) may lead to reduced satiation, increased food intake and is associated with obesity and type 2 diabetes. Domperidone is a dopamine 2 (D2) receptor antagonist with claims of gastrointestinal tract pro-kinetic activity. In humans, domperidone is used as an anti-emetic and treatment for gastrointestinal bloating and discomfort.
Aim
To determine the effect of acute domperidone administration on GE rate and appetite sensations in healthy adults.
Methods
A single-blind block randomised placebo-controlled crossover study assessed 13 healthy adults. Subjects ingested 10 mg domperidone or placebo 30 min before a high-fat (HF) test meal. GE rate was determined using the 13CO2 octanoic acid breath test. Breath samples and subjective appetite ratings were collected in the fasted and during the 360 min postprandial period.
Results
Gastric emptying half-time was similar following placebo (254 ± 54 min) and 10 mg domperidone (236 ± 65 min). Domperidone did not change appetite sensations during the 360 min postprandial period (P > 0.05).
Conclusions
In healthy adults, acute administration of 10 mg domperidone did not change GE or appetite sensations following a HF test meal (NCT01347814).